Scientific

MK5 Microarray Data


Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis - Divided Values

Type II network, divided values. Interestingly most of the proteins in the first 100 positions in this table would occur in the divided ranks table between position 100 and 200, indicating a difference in emphasis between the two simulations but not in the overall function. The fully annotated table, include Ensembl gene identifiers and network values can be found in the supplementary data.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 2913 to 2962 of 6456 in total
Value Type: Ranked
Interaction Map: High confidence
Filtered: 1
\def\wcA{0.14285714285714\textwidth} \def\wcB{0.14285714285714\textwidth} \def\wcC{0.14285714285714\textwidth} \def\wcD{0.14285714285714\textwidth} \def\wcE{0.14285714285714\textwidth} \def\wcF{0.14285714285714\textwidth} \begin{longtable}{|c|c|c|c|c|c|} \hline \parbox{\wcA}{\vspace{3pt}\noindent Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Network Comparison Type\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent network\_comparison\vspace{3pt}}\\ \hline \hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1457\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent eh-domain containing protein 2. [source:swissprot;acc:q9nzn4]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 207.024\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 211.086\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.01962\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent transformer-2 protein homolog (tra-2 alpha). [source:swissprot;acc:q13595]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent 215.328\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 211.267\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent 4.061\vspace{3pt}}}\\\cline{1-2}\cline{4-5} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1458\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent eh-domain containing protein 1 (testilin) (hpast1). [source:swissprot;acc:q9h4m9]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 207.024\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent 211.085\vspace{3pt}}&\\\cline{2-3}\cline{5-6} &\parbox{\wcB}{\vspace{3pt}\noindent eh-domain containing protein 3. [source:swissprot;acc:q9nzn3]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}}&&\parbox{\wcE}{\vspace{3pt}\noindent 211.086\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.01962\vspace{3pt}}\\\cline{1-2}\cline{4-6} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1459\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent importin-alpha re-exporter (chromosome segregation 1-like protein) (cellular apoptosis susceptibility protein). [source:swissprot;acc:p55060]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent 192.336\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 188.637\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.01961\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent reticulon 1 (neuroendocrine-specific protein). [source:swissprot;acc:q16799]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent 207.019\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 211.077\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 4.058\vspace{3pt}}\\\cline{1-2}\cline{4-6} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1460\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent arginine/serine-rich splicing factor 10 (transformer-2-beta) (htra2- beta) (transformer 2 protein homolog) (silica-induced protein 41) (ra301). [source:swissprot;acc:q15815]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent 215.122\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 211.066\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 4.056\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent thyroid receptor interacting protein 12 (trip12). [source:swissprot;acc:q14669]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 205.817\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 209.851\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.0196\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1461\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent mitogen-activated protein kinase 12 (ec 2.7.1.37) (extracellular signal-regulated kinase 6) (erk-6) (erk5) (stress-activated protein kinase-3) (mitogen-activated protein kinase p38 gamma) (map kinase p38 gamma). [source:swissprot;acc:p53778]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 171.231\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 167.177\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 4.054\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent reticulon 1 (neuroendocrine-specific protein). [source:swissprot;acc:q16799]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent 207.019\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 211.077\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent 1.0196\vspace{3pt}}}\\\cline{1-2}\cline{4-5} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1462\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent dihydrolipoamide succinyltransferase component of 2-oxoglutarate dehydrogenase complex, mitochondrial precursor (ec 2.3.1.61) (e2) (e2k). [source:swissprot;acc:p36957]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent 205.817\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 209.851\vspace{3pt}}&\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent sphingosine kinase 1 (ec 2.7.1.-) (sk 1) (spk 1). [source:swissprot;acc:q9nya1]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 171.231\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 167.177\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 4.054\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1463\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent pnas-18. [source:sptrembl;acc:q9bzu3]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 161.056\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 164.211\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.01959\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent udp-n-acetylglucosamine--dolichyl-phosphate n- acetylglucosaminephosphotransferase (ec 2.7.8.15) (gpt) (g1pt) (n-acetylglucosamine-1-phosphate transferase) (glcnac-1-p transferase). [source:swissprot;acc:q9h3h5]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 171.231\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 167.177\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 4.054\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1464\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent poly (adp-ribose) glycohydrolase. [source:refseq;acc:nm\_003631]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 217.351\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 213.18\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.01957\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent rho-gtpase-activating protein 7 (rho-type gtpase-activating protein 7) (deleted in liver cancer 1 protein) (dlc-1) (hp protein) (star-related lipid transfer protein 12) (stard12) (start domain-containing protein 12). [source:swissprot;acc:q96qb1]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 171.231\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 167.177\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent 4.054\vspace{3pt}}}\\\cline{1-2} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1465\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent map kinase-activated protein kinase 2 (ec 2.7.1.-) (mapk-activated protein kinase 2) (mapkap kinase 2) (mapkapk-2). [source:swissprot;acc:p49137]\vspace{3pt}}&&&&\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent mto1 protein homolog (cgi-02). [source:swissprot;acc:q9y2z2]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 217.351\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 213.18\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.01957\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1466\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent neuronal acetylcholine receptor protein, alpha-6 chain precursor. [source:swissprot;acc:q15825]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 171.231\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 167.177\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 4.054\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent reticulon protein 2 (neuroendocrine-specific protein-like 1) (nsp-like protein 1) (nspli). [source:swissprot;acc:o75298]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent 207.022\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 211.073\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.01957\vspace{3pt}}\\\cline{1-2}\cline{4-6} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1467\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent maguk p55 subfamily member 2 (mpp2 protein) (discs, large homolog 2). [source:swissprot;acc:q14168]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent 228.513\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 232.983\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.01956\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent nitrogen fixation cluster-like. [source:refseq;acc:nm\_014301]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 171.231\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 167.177\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 4.054\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1468\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent dr1-associated protein 1; negative cofactor 2 alpha; dr1-associated corepressor. [source:refseq;acc:nm\_006442]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 212.001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 207.937\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.01954\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent star-related lipid transfer protein 13 (stard13) (start domain- containing protein 13) (46h23.2). [source:swissprot;acc:q9y3m8]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 171.231\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 167.177\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 4.054\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1469\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent reticulon protein 3 (neuroendocrine-specific protein-like 2) (nsp-like protein ii) (nsplii). [source:swissprot;acc:o95197]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 207.013\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 211.05\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.0195\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent star-related lipid transfer protein 8 (stard8) (start domain- containing protein 8). [source:swissprot;acc:q92502]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 171.231\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 167.177\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 4.054\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1470\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent glutaminyl-trna synthetase (ec 6.1.1.18) (glutamine--trna ligase) (glnrs). [source:swissprot;acc:p47897]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 221.412\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 217.199\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.0194\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent neuronal acetylcholine receptor protein, alpha-2 chain precursor. [source:swissprot;acc:q15822]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 171.231\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 167.177\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent 4.054\vspace{3pt}}}\\\cline{1-2} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1471\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent mitogen-activated protein kinase-activated protein kinase 3; mapkap kinase 3. [source:refseq;acc:nm\_004635]\vspace{3pt}}&&&&\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent spermidine synthase (ec 2.5.1.16) (putrescine aminopropyltransferase) (spdsy). [source:swissprot;acc:p19623]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 221.412\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 217.199\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent 1.0194\vspace{3pt}}}\\\cline{1-2} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1472\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent glycyl-trna synthetase (ec 6.1.1.14) (glycine--trna ligase) (glyrs). [source:swissprot;acc:p41250]\vspace{3pt}}&&&&\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent mitogen-activated protein kinase 14 (ec 2.7.1.37) (mitogen-activated protein kinase p38alpha) (map kinase p38alpha) (cytokine suppressive anti-inflammatory drug binding protein) (csaid binding protein) (csbp) (max-interacting protein 2) (map kinase mxi2) (sapk2a). [source:swissprot;acc:q16539]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 171.231\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 167.177\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 4.054\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1473\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent glutamyl trna synthetase. [source:sptrembl;acc:o14563]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 221.412\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 217.199\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.0194\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent neuronal acetylcholine receptor protein, alpha-4 chain precursor. [source:swissprot;acc:p43681]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 171.231\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 167.177\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 4.054\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1474\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent importin beta-3 subunit (karyopherin beta-3 subunit) (ran-binding protein 5). [source:swissprot;acc:o00410]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 218.582\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 214.427\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.01938\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent neuronal acetylcholine receptor protein, alpha-3 chain precursor. [source:swissprot;acc:p32297]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 171.231\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 167.177\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 4.054\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1475\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent kynureninase (ec 3.7.1.3) (l-kynurenine hydrolase). [source:swissprot;acc:q16719]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 181.882\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 178.438\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.0193\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent sphingosine kinase 2 (ec 2.7.1.-) (sk 2) (spk 2). [source:swissprot;acc:q9nra0]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 171.231\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 167.177\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 4.054\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1476\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent ran-gtp binding protein (fragment). [source:sptrembl;acc:o60518]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 218.591\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 214.457\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.01928\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent reticulon protein 2 (neuroendocrine-specific protein-like 1) (nsp-like protein 1) (nspli). [source:swissprot;acc:o75298]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent 207.022\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 211.073\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 4.051\vspace{3pt}}\\\cline{1-2}\cline{4-6} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1477\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent reticulon protein 3 (neuroendocrine-specific protein-like 2) (nsp-like protein ii) (nsplii). [source:swissprot;acc:o95197]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent 207.013\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 211.05\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 4.037\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent transformer-2 protein homolog (tra-2 alpha). [source:swissprot;acc:q13595]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent 215.328\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 211.267\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent 1.01922\vspace{3pt}}}\\\cline{1-2}\cline{4-5} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1478\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent arginine/serine-rich splicing factor 10 (transformer-2-beta) (htra2- beta) (transformer 2 protein homolog) (silica-induced protein 41) (ra301). [source:swissprot;acc:q15815]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent 215.122\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 211.066\vspace{3pt}}&\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent thyroid receptor interacting protein 12 (trip12). [source:swissprot;acc:q14669]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 205.817\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 209.851\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent 4.034\vspace{3pt}}}\\\cline{1-2} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1479\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent dihydrolipoamide succinyltransferase component of 2-oxoglutarate dehydrogenase complex, mitochondrial precursor (ec 2.3.1.61) (e2) (e2k). [source:swissprot;acc:p36957]\vspace{3pt}}&&&&\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent maguk p55 subfamily member 6 (veli-associated maguk 1) (vam-1). [source:swissprot;acc:q9nzw5]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent 228.469\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 232.855\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.0192\vspace{3pt}}\\\cline{1-2}\cline{4-6} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1480\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent cleavage and polyadenylation specific factor 6, 68 kd subunit; pre-mrna cleavage factor im (68kd); cleavage and polyadenylation specific factor 6, 68kd subunit; pre-mrna cleavage factor i, 68kd subunit. [source:refseq;acc:nm\_007007]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent 218.664\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 214.55\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.01918\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent mitogen-activated protein kinase kinase kinase 7 (ec 2.7.1.-) (transforming growth factor-beta-activated kinase 1) (tgf-beta- activated kinase 1). [source:swissprot;acc:o43318]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent 213.251\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 209.264\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 3.987\vspace{3pt}}\\\cline{1-2}\cline{4-6} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1481\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent alpha-centractin (centractin) (centrosome-associated actin homolog) (actin-rpv) (arp1). [source:swissprot;acc:p42024]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent 225.148\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 221.177\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 3.971\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent cell division cycle protein 23; anaphase-promoting complex subunit 8. [source:refseq;acc:nm\_004661]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 208.432\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 204.516\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.01915\vspace{3pt}}\\\hline nd{longtable}
Legend:
- Rank is the rank after comparing the two networks
- Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray
- Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.
- Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them
- Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.
- Filtered specifies whether we only included the high confidence microarry measurements or not.

- http://analysis.yellowcouch.org/